Anti-Hypertension Drugs Market Size, Share and Forecast 2026
The Anti-Hypertension Drugs Market is estimated to be USD XXbillion in 2018, and the market has grown at a CAGR of XX% in the period 2019-2026.
(EMAILWIRE.COM, September 13, 2019 ) Market Overview:
The Anti Hypertension Therapeutics Market is estimated to decline at a CAGR of XX% during 2019-2026 and grow after that. Patent expiry of the major drugs is the primary reason for the decline in the market during 2019-2026 while new launches are forecasted to increase the demand from 2019-2026.
Market Dynamics:
High penetration of fixed dosage drugs, rise in prevalence of the global population suffering with hypertension, growth in the chronic diseases, and growing patient assistance programmes are some of the major factors driving the growth of the market.
Patent expiry of major drugs, the adverse impact of drugs, the presence of a considerable number of substitutes, and poor patient compliance are the significant factors challenging the growth of the market in the forecasted period.
Market Segmentation:
Segmentation by Therapy Type
• Calcium Channel Blockers
• Diuretics
• Beta Blockers Vasodilators
• Angiotensin Converting Enzyme Inhibitors
• Alpha Blockers
• Angiotensin Receptor Blockers
• Renin Inhibitors
• Endothelin receptor antagonist
• Prostacyclin Analogs
• Phosphodiesterase inhibitors
• sGC stimulators
Segmentation by Drug Class
• Systemic Hypertension
• Pulmonary Arterial Hypertension
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• Daiichi Sankyo
• Boehringer Ingelheim
• Sanofi
• Pfizer
• Merck
• Lupin
• Others
View full report: https://www.datamintelligence.com/research-report/anti-hypertension-drugs-market
Download free sample: https://www.datamintelligence.com/download-sample/adaptive-robotics-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
The Anti Hypertension Therapeutics Market is estimated to decline at a CAGR of XX% during 2019-2026 and grow after that. Patent expiry of the major drugs is the primary reason for the decline in the market during 2019-2026 while new launches are forecasted to increase the demand from 2019-2026.
Market Dynamics:
High penetration of fixed dosage drugs, rise in prevalence of the global population suffering with hypertension, growth in the chronic diseases, and growing patient assistance programmes are some of the major factors driving the growth of the market.
Patent expiry of major drugs, the adverse impact of drugs, the presence of a considerable number of substitutes, and poor patient compliance are the significant factors challenging the growth of the market in the forecasted period.
Market Segmentation:
Segmentation by Therapy Type
• Calcium Channel Blockers
• Diuretics
• Beta Blockers Vasodilators
• Angiotensin Converting Enzyme Inhibitors
• Alpha Blockers
• Angiotensin Receptor Blockers
• Renin Inhibitors
• Endothelin receptor antagonist
• Prostacyclin Analogs
• Phosphodiesterase inhibitors
• sGC stimulators
Segmentation by Drug Class
• Systemic Hypertension
• Pulmonary Arterial Hypertension
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• Daiichi Sankyo
• Boehringer Ingelheim
• Sanofi
• Pfizer
• Merck
• Lupin
• Others
View full report: https://www.datamintelligence.com/research-report/anti-hypertension-drugs-market
Download free sample: https://www.datamintelligence.com/download-sample/adaptive-robotics-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results